Evidence map›Paper›PMID 24849722›Full record

ArticleThe Lancet. Infectious diseases2014

Artemisinin resistance in Plasmodium falciparum.

Chanaki Amaratunga, Benoit Witkowski, Nimol Khim, Didier Menard, Rick M Fairhurst

Abstract readLetterComment
In one paragraph

Article in The Lancet. Infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Review
  2. Article
  3. Artemisinin pressure in field isolates can select highly resistantAntimicrobial agents and chemotherapy · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular Surveillance andFrontiers in cellular and infection microbiology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. DecreasedAntimicrobial agents and chemotherapy · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Chanaki AmaratungaLaboratory of Malaria and Vector Research, NIAID/National Institutes of Health, Rockville, MD 20852, USA.
Benoit WitkowskiMalaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Nimol KhimMalaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Didier MenardMalaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Rick M FairhurstLaboratory of Malaria and Vector Research, NIAID/National Institutes of Health, Rockville, MD 20852, USA. Electronic address: rfairhurst@niaid.nih.gov.

Funding

International Research in Cambodia: Tropical Medicine and Vector Research ZIAAI001066 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI YEK, CHRISTINA · 2009 to 2025
$10.8M
Malaria Pathogenesis and Human ImmunityZIAAI001000 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FAIRHURST, RICK · 2009 to 2017
$9.3M
Malaria Pathogenesis and Human ImmunityZ01AI001000 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI FAIRHURST, RICK · 2007 to 2008
$826k
Intramural NIH HHS Z01 AI001000
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimalarialsArtemisininsHumansMalaria, FalciparumPlasmodium falciparumAntimalarialsArtemisinins

Identifiers

PMID24849722
PMCPMC4573664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.